JPMorgan Miss Opens Bank Earnings Season as 5.3% Yields Put the Fed on Edge

October 13, 2026 · 62 sources

Quick Hits

JPMorgan (JPM) whiffed on Q3 — earnings disappointed as markets revenue softened, sending the stock lower and setting a cautious tone for Tuesday's big-bank kickoff, the first real read on how 5%-plus Treasury yields are stressing the economy (Seeking Alpha, MarketWatch).
This week's inflation data is the main event. Fed officials want to hold off a rate hike at their late-October meeting — but a troubling rise in prices could force a move (MarketWatch).
Goldman Sachs flipped bullish on stocks for the rest of the year, citing earnings strength and a market that has gotten cheaper (MarketWatch).
Microsoft (MSFT) unveiled Maia 300 on Monday, its third generation of in-house AI silicon, ramping from 2027 — the latest twist in the custom-chip-versus-Nvidia race (Motley Fool).
Options traders are pricing in violent swings beginning later this month after a stretch of sideways drift and dwindling volume in U.S. equities (MarketWatch).

Calm before the storm. Major indexes have mostly drifted sideways in recent sessions as trading volume has thinned, following a fresh record high for the S&P 500 last week (MarketWatch, Motley Fool).
The bond market remains the year's defining story. The 10-year Treasury recently touched 5.3% — its highest level since 2007 — amid a global bond sell-off that Motley Fool columnists warn has historically spelled trouble for stocks.
Positioning is split. Goldman's bullish turn is running against a stack of bearish Fool commentary: a crash prediction built on nearly seven decades of history (citing climbing oil prices amid ongoing conflicts), a "rare warning signal" appearing for only the second time ever, and the bond rout itself.
Korea's market is in freefall, with skepticism rising over how long semiconductor-industry profitability can be sustained (MarketWatch).
Crypto is feeling the yield squeeze: Ethereum trades near $2,500, 47% below its high, and Fool argues Treasury yields above 5% are outright bearish for Bitcoin as fixed income turns fiercely competitive.
Watch this week: inflation data, ASML's earnings Wednesday, Social Security's annual announcement Wednesday, and the late-October window options markets are bracing for.

JPMorgan (JPM): Shares traded lower after Q3 results disappointed on softening markets revenue — an inauspicious start to a bank-earnings week investors hope will clarify the economy's footing in a rising-yield environment (Seeking Alpha, MarketWatch).
UnitedHealth (UNH): A bright spot — the insurer held its medical-cost ratio to 88.4% in Q3 while reining in care spending, and raised its outlook yet again (MarketWatch).
InMode (INMD): Preannounced Q3 revenue of $91.8M–$92M (Seeking Alpha).
TSMC (TSM): Last quarter's revenue growth accelerated faster than expected; one Motley Fool analyst calls it the top AI chip stock to buy, with Gartner projecting AI infrastructure spending approaching $2 trillion.
Ahead: ASML — Europe's most valuable company — reports Q3 Wednesday before the Amsterdam open, kicking off tech earnings season (MarketWatch).

The Fed's dilemma, in one headline: Officials would prefer to hold off a rate hike this month, but this week's inflation print decides whether they get that luxury. A troubling rise in prices might trigger a move at the late-October meeting (MarketWatch).
Chair Kevin Warsh's FOMC has already fired a warning shot at what Fool calls the second-priciest stock market in history, with inflation still above the Fed's 2% target (Motley Fool).
Social Security's three annual changes land Wednesday, Oct. 14 — adjustments to 2027 payment amounts, rules, and thresholds that Fool says may surprise many Americans.

Semiconductors are the market's battleground. Korean chip-exposed stocks are tumbling on cycle skepticism even as TSMC accelerates and Fool debates Broadcom (AVGO) versus Qualcomm (QCOM) for 2026. Microsoft's Maia 300 adds a third generation of homegrown silicon ramping from 2027 — though Fool still ranks Nvidia (NVDA) the chip stock to buy. Separately, Nvidia and Micron (MU) took bad news from an unlikely corner: Australia, which has become a major AI data-center hub.
Healthcare heavyweights flex. Eli Lilly (LLY) trading above $1,000 has investors buzzing about a possible stock split; Seeking Alpha flags LLY and AbbVie (ABBV) among mega-cap healthcare names with A+ profitability grades, while Fool weighs AbbVie's reliable dividend growth against Lilly's metabolic-drug growth engine.
Consumer bifurcation continues: as shoppers trade down, Fool highlights five brands that still hold real pricing power.

Shopify (SHOP) popped nearly 5% Monday after an analyst delivered a meaty price-target increase (Motley Fool).
On the downside: Carter's (CRI) slipped after an aggressive analyst target cut, and Harmony Biosciences (HRMY) got hammered on news of a CEO change (Motley Fool).
M&A and buybacks: Symbotic (SYM) is expanding into Europe via its acquisition of cellumation; Ollie's (OLLI) gained after adding to its buyback firepower (Seeking Alpha).
Berkshire Hathaway (BRK.A, BRK.B): New CEO Greg Abel is already reshaping the portfolio in his first months succeeding Warren Buffett (Motley Fool).
Defense: Anduril — Palmer Luckey's defense startup — holds a $2.9 billion Navy contract that, per Fool, may already make it America's second-largest Navy warship builder.
Insider buying at Banco Bradesco (BBD): a director bought $843,000 of stock at $17.98 a share, while an executive added roughly $1 million more in separate Form 4 filings (Motley Fool).